Alfonso Quintas Cardama

Insider Reports History

Entity
Individual
Location
C/O Tcr2 Therapeutics Inc., 100 Binney Street, Cambridge, MA
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Alfonso Quintas-Cardama
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alfonso Quintas Cardama:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief Medical Officer Stock Option (right to buy) 60K $184K $3.06 Jan 24, 2024 Direct
TCR2 THERAPEUTICS INC. Chief Medical Officer Common Stock 0 $1.72 Jun 1, 2023 Direct
TCR2 THERAPEUTICS INC. Chief Medical Officer Restricted Stock Unit 0 Jun 1, 2023 Direct
TCR2 THERAPEUTICS INC. Chief Medical Officer Stock Option (Right to Buy) 0 $0.74 Jun 1, 2023 Direct

Insider Reports Filed by Alfonso Quintas Cardama

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. Jan 24, 2024 1 $184K 4 Jan 25, 2024 Chief Medical Officer
FHTX Foghorn Therapeutics Inc. Sep 11, 2023 1 $2.06M 4 Sep 13, 2023 Chief Medical Officer
FHTX Foghorn Therapeutics Inc. Sep 11, 2023 0 $0 3 Sep 13, 2023 Chief Medical Officer
TCRR TCR2 THERAPEUTICS INC. Jun 1, 2023 10 $0 4 Jun 1, 2023 Chief Medical Officer
TCRR TCR2 THERAPEUTICS INC. Dec 15, 2022 2 $0 4 Dec 19, 2022 Chief Medical Officer
TCRR TCR2 THERAPEUTICS INC. Dec 9, 2022 3 -$15.1K 4 Dec 13, 2022 Chief Medical Officer
TCRR TCR2 THERAPEUTICS INC. Dec 7, 2022 2 -$10.1K 4 Dec 9, 2022 Chief Medical Officer
TCRR TCR2 THERAPEUTICS INC. Dec 5, 2022 2 -$10.1K 4 Dec 7, 2022 Chief Medical Officer
TCRR TCR2 THERAPEUTICS INC. Dec 1, 2022 5 -$5.05K 4 Dec 5, 2022 Chief Medical Officer
TCRR TCR2 THERAPEUTICS INC. Nov 17, 2022 12 $0 4 Nov 18, 2022 Chief Medical Officer
TCRR TCR2 THERAPEUTICS INC. Aug 31, 2021 4 $66K 4 Dec 10, 2021 Chief Medical Officer